Kingsview Wealth Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-109,652
Closed -$2.13M 1050
2023
Q4
$2.13M Buy
109,652
+30,792
+39% +$568K 0.06% 266
2023
Q3
$1.67M Buy
78,860
+67,284
+581% +$1.75M 0.06% 322
2023
Q2
$384K Sell
11,576
-22,068
-66% -$812K 0.02% 661
2023
Q1
$1.32M Buy
+33,644
New +$1.4M 0.06% 324
2021
Q1
Sell
-16,160
Closed -$883K 912
2020
Q4
$883K Sell
16,160
-104
-0.6% -$5.47K 0.06% 306
2020
Q3
$815K Buy
+16,264
New +$771K 0.07% 265

Other funds holding NUS

Kingsview Wealth Management's NUS Position: Q1 2024 in Review

Kingsview Wealth Management sold out of Nu Skin (NUS) in Q1 2024, closing a stake of 109,652 shares — an estimated $2.13M sold.

Kingsview Wealth Management first reported a position in NUS in Q3 2020 and held it in 6 quarters. The position peaked at $2.13M in Q4 2023. 198 funds tracked by Wall St. Rank hold NUS as of Q1 2024.

  • Kingsview Wealth Management reported no remaining Nu Skin position as of Q1 2024 after selling out during the quarter.
  • Kingsview Wealth Management sold 109,652 Nu Skin shares in Q1 2024, an estimated $2.13M.
  • Kingsview Wealth Management first reported a position in Nu Skin in Q3 2020 and held it in 6 quarters.
  • Kingsview Wealth Management's Nu Skin position peaked at $2.13M in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Nu Skin as of Q1 2024.

Based on Kingsview Wealth Management's 13F filing for Q1 2024, filed 9 May 2024.